A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
-5.66%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$133M
AUM Growth
+$133M
(-24%)
Cap. Flow
-$435K
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
99.93%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ZLCS
ZALICUS INC COM NEW
ZLCS
|
$435K |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$129 |
| 3 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$3 |
Sector Composition
| 1 | Healthcare | 53.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTLA
1
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $32M | 24.08% |
1,240,912
-5
| -0% | -$129 |
|
|
RNA
2
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $29M | 21.82% |
6,213,924
| – | – |
|
3
Supernus Pharmaceuticals
SUPN
$2.53B
| $27.1M | 20.43% |
3,600,000
| – | – |
|
|
AMRN
4
Amarin Corp
AMRN
$311M
| $15.9M | 11.95% |
8,087,486
| – | – |
|
|
CEMP
5
DELISTED
Cempra, Inc.
CEMP
| $8.85M | 6.67% |
714,285
| – | – |
|
|
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
| $8.01M | 6.04% |
2,335,218
| – | – |
|
7
Achieve Life Sciences
ACHV
$152M
| $5.04M | 3.79% |
603,740
| – | – |
|
|
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.25M | 3.2% |
102,200
| – | – |
|
|
ANTH
9
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.34M | 1.01% |
437,994
-1
| -0% | -$3 |
|
|
HPTX
10
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.26M | 0.95% |
62,500
| – | – |
|
|
ZLCS
11
DELISTED
ZALICUS INC COM NEW
ZLCS
| $87K | 0.07% |
78,966
-394,834
| -83% | -$435K |
|